These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

71 related articles for article (PubMed ID: 7053260)

  • 1. Phase II study of high-dose intermittent cycloleucine in colorectal malignancies.
    Dindogru A; Leichman LP; Cummings G; Baker LH
    Cancer Treat Rep; 1982 Jan; 66(1):203-4. PubMed ID: 7053260
    [No Abstract]   [Full Text] [Related]  

  • 2. Phase II study on oral N-methylformamide in metastatic colorectal cancer.
    Planting AS; Klijn JG; Verweij J; Stoter G
    Cancer Treat Rep; 1987 Dec; 71(12):1293-4. PubMed ID: 3690540
    [No Abstract]   [Full Text] [Related]  

  • 3. Phase II study of 3-deazauridine in advanced colorectal adenocarcinoma.
    Bruno S; Creaven PJ; Ledesma E; Poster D; Yoon J; Mittelman A
    Am J Clin Oncol; 1982 Feb; 5(1):69-71. PubMed ID: 7081140
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Five-year results of a randomized controlled trial of adjuvant chemotherapy for curatively resected colorectal carcinoma. The Colorectal Cancer Chemotherapy Study Group of Japan.
    Jpn J Clin Oncol; 1995 Jun; 25(3):91-103. PubMed ID: 7596054
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phase II study of tiazofurin in colorectal cancer: a National Cancer Institute of Canada Study.
    Maroun JA; Eisenhauer E; Cripps C; Maksymiuk A
    Cancer Treat Rep; 1987 Dec; 71(12):1297-8. PubMed ID: 3690542
    [No Abstract]   [Full Text] [Related]  

  • 6. Phase II evaluation of DON (6-diazo-5-oxo-L-norleucine) in patients with advanced colorectal carcinoma.
    Lynch G; Kemeny N; Casper E
    Am J Clin Oncol; 1982 Oct; 5(5):541-3. PubMed ID: 7180833
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phase II study of hycanthone in patients with advanced colorectal carcinoma.
    Schutt AJ; Dalton RJ; Kovach JS; Moertel CG; O'Connell MJ
    Cancer Treat Rep; 1983 Jun; 67(6):593-4. PubMed ID: 6861166
    [No Abstract]   [Full Text] [Related]  

  • 8. Phase I study of UFT plus leucovorin in advanced colorectal cancer: a double modulation proposal.
    González Barón M; Feliu J; Ordoñez A; Colmenarejo A; Espinosa E; Zamora P; de la Gandara I; Jalon JI
    Anticancer Res; 1993; 13(3):759-62. PubMed ID: 8317909
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phase II trial of bisantrene in advanced colorectal cancer: a cancer and leukemia group B study.
    Perry MC; Forastiere AA; Richards F; Weiss RB; Anbar D
    Cancer Treat Rep; 1982 Nov; 66(11):1997-8. PubMed ID: 7139643
    [No Abstract]   [Full Text] [Related]  

  • 10. Phase I/II study of oxaliplatin with weekly bolus fluorouracil and high-dose leucovorin (ROX) as first-line therapy for patients with colorectal cancer.
    Yamada Y; Ohtsu A; Boku N; Miyata Y; Shimada Y; Doi T; Muro K; Muto M; Hamaguchi T; Mera K; Yano T; Tanigawara Y; Shirao K
    Jpn J Clin Oncol; 2006 Apr; 36(4):218-23. PubMed ID: 16684860
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phase II trial of bisantrene in advanced colorectal carcinoma.
    Ahmed T; Kemeny NE; Michaelson RA; Harper HD
    Cancer Treat Rep; 1983 Mar; 67(3):307-8. PubMed ID: 6831479
    [No Abstract]   [Full Text] [Related]  

  • 12. A phase II study of weekly 24-hour infusion of high-dose 5-fluorouracil and leucovorin (HDFL) in the treatment of recurrent or metastatic colorectal cancers.
    Yeh KH; Cheng AL; Lin MT; Hong RL; Hsu CH; Lin JF; Chang KJ; Lee PH; Chen YC
    Anticancer Res; 1997; 17(5B):3867-71. PubMed ID: 9427794
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phase II study of PCNU in colorectal carcinoma.
    Mitchell EP; Killen JY; Smith FP; Willis LL; Schein PS; Woolley PV
    Cancer Treat Rep; 1981; 65(11-12):1129-30. PubMed ID: 7296558
    [No Abstract]   [Full Text] [Related]  

  • 14. Phase II trial of 4-demethoxydaunorubicin in advanced colorectal carcinoma.
    Harper HD; Kemeny NE; Ahmed T; Cheng E; Arena F; Sordillo P; Faye L
    Cancer Treat Rep; 1984 Apr; 68(4):689-90. PubMed ID: 6585273
    [No Abstract]   [Full Text] [Related]  

  • 15. Phase II clinical trial of tricyclic nucleoside phosphate for advanced colorectal cancer.
    O'Connell MJ; Rubin J; Hahn RG; Kvols LK; Moertel CG
    Cancer Treat Rep; 1987 Mar; 71(3):333-4. PubMed ID: 3815402
    [No Abstract]   [Full Text] [Related]  

  • 16. Phase II trial of mitoxantrone in advanced colorectal cancer.
    Bonnem EM; Mitchell EP; Woolley PV; Smith FP; Neefe J; Smith L; Schein PS
    Cancer Treat Rep; 1982 Nov; 66(11):1995-6. PubMed ID: 7139642
    [No Abstract]   [Full Text] [Related]  

  • 17. Phase II trial: mitomycin c and methotrexate combination therapy for advanced colorectal carcinoma.
    Budman DR; Schulman P; Vinciguerra V; Degnan T
    Cancer Treat Rep; 1981; 65(5-6):535. PubMed ID: 7237477
    [No Abstract]   [Full Text] [Related]  

  • 18. Vindesine in the treatment of advanced colorectal cancer: a phase II study.
    Diaz-Rubio E; Martin-Jimenez M
    Cancer Treat Rep; 1984 Mar; 68(3):555-6. PubMed ID: 6704985
    [No Abstract]   [Full Text] [Related]  

  • 19. Phase II evaluation of metoprine in patients with advanced colorectal carcinoma.
    Lynch G; Kemeny N; Currie V
    Cancer Treat Rep; 1981; 65(1-2):127-8. PubMed ID: 7226162
    [No Abstract]   [Full Text] [Related]  

  • 20. Phase II trial of iv 6-thioguanine in advanced colorectal carcinoma.
    Britell JC; Moertel CG; Kvols LK; O'Connell MJ; Rubin J; Schutt AJ
    Cancer Treat Rep; 1981; 65(9-10):909-10. PubMed ID: 7273027
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.